Pancreatic cancer (PC) has a poor prognosis and limited response to therapies.
Combinatorial approaches, such as natural product-based therapies, can enhance anticancer efficacy while minimizing side effects.
This study evaluated M. sativa's anticancer properties and its potential as adjunctive therapy with Gemcitabine (GEM) to sensitize PANC-1 cells to chemotherapy.
